Association between extent of axillary lymph node dissection and patient, tumor, surgeon, and hospital factors in patients with early breast cancer

被引:37
|
作者
Petrik, DW
McCready, DR
Sawka, CA
Goel, V
机构
[1] Princess Margaret Hosp, Dept Surg Oncol, Toronto, ON M5G 2M9, Canada
[2] Univ Alberta, Dept Radiat Oncol, Edmonton, AB, Canada
[3] Univ Hlth Network, Div Gen Surg, Toronto, ON, Canada
[4] Univ Toronto, Dept Med, Toronto, ON, Canada
[5] Toronto Sunnybrook Reg Canc Ctr, Toronto, ON, Canada
[6] Inst Clin Evaluat Sci, Toronto, ON, Canada
[7] Univ Toronto, Dept Hlth Adm, Toronto, ON M5S 1A1, Canada
[8] Univ Toronto, Dept Publ Hlth Sci, Toronto, ON M5S 1A1, Canada
关键词
breast neoplasms; lymph node excision; axilla; academic medical centers; treatment outcome; lymphatic metastases;
D O I
10.1002/jso.10198
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and Objectives: Axillary lymph node dissection (ALND) in patients with breast cancer is crucial for accurate staging, provides excellent regional tumor control, and is included in the standard of care for the surgical treatment of breast cancer. However, the extent of ALND varies, and the extent of dissection and the number of lymph nodes that comprise an optimal axillary dissection are under debate. Despite conflicting evidence, several studies have shown that improved survival is correlated with more lymph nodes removed in both node-negative and node-positive patients. The purpose of this study is to determine which patient, tumor, surgeon, and hospital characteristics are associated with the number of nodes excised in early breast cancer patients. Methods: A random sample of 938 women with node-negative breast cancer was drawn from the Ontario Cancer Registry and the data supplemented with chart reviews. The extent of axillary dissection was studied by examining the number of nodes examined in relation to the patient, tumor, surgeon, and hospital factors. Results: The mean number of lymph nodes excised was 9.8 (SD = 4.8; range, 1-31), and 49% of patients had greater than or equal to 10 nodes excised. Lower patient age was associated with the excision of more lymph nodes ( greater than or equal to10 nodes: 63% of patients <40 years vs. 38% of patients greater than or equal to80 years). Surgeon academic affiliation and surgery in a teaching hospital were highly correlated with each other and were significantly associated with the excision of greater than or equal to10 nodes. The number of nodes excised was not associated with any tumor factors, nor with the breast operation performed. These results were confirmed with multivariable models. Conclusions: Even though the number of lymph nodes found in the pathologic specimen can be influenced by factors other than surgical technique (e.g., number of nodes present, specimen handling, and pathologic examination), this study shows significant variation of this variable and an association with several patient and surgeon/hospital factors. This variation and the association with survival warrant further study and effort at greater consistency. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:84 / 90
页数:7
相关论文
共 50 条
  • [1] Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer
    Julie Ann Sosa
    Marie Diener-West
    Yuriy Gusev
    Michael A. Choti
    Julie R. Lange
    William C. Dooley
    Martha A. Zeiger
    Annals of Surgical Oncology, 1998, 5 : 140 - 149
  • [2] Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer
    Sosa, JA
    Diener-West, M
    Gusev, Y
    Choti, MA
    Lange, JR
    Dooley, WC
    Zeiger, MA
    ANNALS OF SURGICAL ONCOLOGY, 1998, 5 (02) : 140 - 149
  • [3] Patient Preferences for Axillary Dissection in Sentinel Lymph Node Positive Early Breast Cancer
    Chang, David W. S.
    Bressel, Mathias
    Hansen, Carmen
    Blinman, Prunella
    Schofield, Penelope
    Chua, Boon
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 118 - 119
  • [4] Minimize the extent and morbidity of axillary dissection for node-positive breast cancer patients: implementation of axillary lymph node dissection based on breast lymphatics level
    Qianqian Yuan
    Jinxuan Hou
    Yukun He
    Yiqian Liao
    Lewei Zheng
    Gaosong Wu
    BMC Cancer, 21
  • [5] Minimize the extent and morbidity of axillary dissection for node-positive breast cancer patients: implementation of axillary lymph node dissection based on breast lymphatics level
    Yuan, Qianqian
    Hou, Jinxuan
    He, Yukun
    Liao, Yiqian
    Zheng, Lewei
    Wu, Gaosong
    BMC CANCER, 2021, 21 (01)
  • [6] Axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases
    Gomez Dorronsoro, L. M.
    Aizcorbe Garralda, M.
    De Pablo Angel, Sanz M.
    Dominguez, F.
    Trujillo, R.
    De Miguel Medina, C.
    Ruiz De Azua, Y.
    Gonzalez Alvarez, G.
    VIRCHOWS ARCHIV, 2009, 455 : 94 - 94
  • [7] Risk factors for early postoperative psychological problems in breast cancer patients after axillary lymph node dissection
    Yoshiteru Akezaki
    Eiji Nakata
    Masato Kikuuchi
    Ritsuko Tominaga
    Hideaki Kurokawa
    Makiko Hamada
    Kenjiro Aogi
    Shozo Ohsumi
    Shinsuke Sugihara
    Breast Cancer, 2020, 27 : 284 - 290
  • [8] Risk factors for early postoperative psychological problems in breast cancer patients after axillary lymph node dissection
    Akezaki, Yoshiteru
    Nakata, Eiji
    Kikuuchi, Masato
    Tominaga, Ritsuko
    Kurokawa, Hideaki
    Hamada, Makiko
    Aogi, Kenjiro
    Ohsumi, Shozo
    Sugihara, Shinsuke
    BREAST CANCER, 2020, 27 (02) : 284 - 290
  • [9] Axillary lymph node dissection in patients with breast cancer and sentinel lymph node micrometastasis or isolated tumor cells: is it necessary?
    Attene, Federico
    Paliogiannis, Panagiotis
    Scognamillo, Fabrizio
    Trignano, Emilio
    Pala, Carlo
    Trignano, Mario
    TUMORI JOURNAL, 2012, 98 (03): : 320 - 323
  • [10] Early experience of robotic axillary lymph node dissection in patients with node-positive breast cancer
    Ahn, Jee Hyun
    Park, Jung Min
    Choi, Soon Bo
    Go, Jieon
    Lee, Jeea
    Kim, Jee Ye
    Park, Hyung Seok
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 198 (03) : 405 - 412